NCT00367445View on ClinicalTrials.gov

A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and Lantus

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2006

Study Completion Date

February 28, 2007

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Inhaled Human Insulin (Exubera)

DRUG

Insulin Glargine (Lantus)

Trial Locations (1)

Unknown

Pfizer Investigational Site, Chula Vista

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY